// App-Quantinova.ai

Sa2031 : Accelerated Clearance of Serum Infliximab During Induction Therapy for Acute Ulcerative Colitis Is Associated With Treatment Failure.

Researchers

Presenter

  • Sanjay Murthy

Principal Investigators

  • Anna Iacono

  • Mark S. Silverberg

  • Gordon R. Greenberg

Medical Centers

  • Department of Surgery, University of Toronto, Toronto, ON, Canada

  • Division of Gastroenterology, Mount Sinai Hospital, Toronto, Ontario, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Ulcerative colitis

Biomarkers

  • Human albumin

Drug/Treatment

  • Infliximab

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved